Recombinant Human Asparagine Synthetase/ASNS His Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 10193-AS

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
10193-AS-020
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

HEK293

Accession #

P08243-1

Conjugate

Unconjugated

Applications

Enzyme Activity

View all Asparagine Synthetase/ASNS Proteins and Enzymes »

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human Asparagine Synthetase/ASNS protein
Cys2-Ala561
with C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Cys

Predicted Molecular Mass

65 kDa

SDS-PAGE

58-65 kDa, under reducing conditions

Activity

Measured by its ability to produce diphosphate during the conversion of aspartate and glutamine to asparagine and glutamate.
The specific activity is >100 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Human Asparagine Synthetase/ASNS His Protein, CF

Recombinant Human Asparagine Synthetase/ASNS His Protein SDS-PAGE

Recombinant Human Asparagine Synthetase/ASNS His Protein SDS-PAGE

2 μg/lane of Recombinant Human Asparagine Synthetase/ASNS His-tag was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® blue staining, showing a band at ~62 kDa under reducing conditions.

Formulation, Preparation and Storage

10193-AS
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl, TCEP and Glycerol.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Asparagine Synthetase/ASNS

Asparagine Synthetase (ASNS) represents a single mammalian-expressed enzyme that catalyzes the synthesis of asparagine and glutamate from aspartate and glutamine in an ATP-dependent amidotransferase reaction (1). Although the name focuses attention on its function in asparagine synthesis, the reaction catalyzed by ASNS also impacts glutamine, aspartate and glutamate homeostasis. Human ASNS is a class II or N-terminal nucleophile glutamine amidotransferase (2) and is a cytosolic, 65 kDa ATP-dependent homodimer where each monomer is composed of two functional domains based on modeling: an N-terminal domain that contains the glutamine-binding pocket and the C-terminal domain that contains the ATP-binding site (3). Although ubiquitously expressed at low levels in many organs, expression is particularly high in the pancreas (4).  Several mutations in the ASNS gene which are suspected to result in decreased activity cause Asparagine Synthetase Deficiency (ASD) (5). ASD has been characterized as a neurological disorder with severe impacts on psychomotor development and mortality at a young age supporting involvement of asparagine in neural development (6). As deficiency of ASNS leads to extracellular asparagine dependence, the brain is highly susceptible to deficiency due to the blood brain barrier limitation of available amino acids (7). Interest in targeting asparagine metabolism in cancer is based on the observation that unlike most normal cells, in acute lymphatic leukemia (ALL) there is little or no detectable ASNS nor upregulation during substrate deprivation in leukemic lymphoblasts making the transformed cells specifically sensitive to extracellular asparagine depletion (5, 8-10). Lower ASNS levels correlates with reduced proliferative capacity while subsequent supplementation of asparagine led to increased cell survival (11). Treatment with bacterial asparaginase as a component in combinatorial chemotherapy depletes plasma asparagine levels and results in starving leukemia cells in ALL to prevent growth (12) and can be applied more broadly to solid tumors where ASNS expression levels correlate with asparaginase sensitivity (10, 13-15).

References

  1. Richards, N. G. J. and Schuster, S.M. (1998) Adv. Enzymol. 72:145.
  2. Zalkin, H. and J. L. Smith (1998) Adv. Enzymol. Relat. Areas Mol. Biol. 72:87.
  3. Larsen, T. M. et al. (1999) Biochemistry. 38:16146
  4. Milman, H. A. and D. A. Cooney (1974) Biochem. J. 142:27.
  5. Lomelino, C. L. et al. (2017) J. Biol. Chem. 292:19952.
  6. Ruzzo, E. K. et al. (2013) Neuron. 80:429.
  7. Hawkins, R. A. et al. (2006) J. Nutr. 136:218S.
  8. Haskell, C. M. et al. (1969) Biochem. Pharmacol. 18:2578.
  9. Aslanian, A. M. et al. (2001) Biochem. J. 357:321.
  10. Su, N. et al. (2008) Pediatr. Blood Cancer. 50:274.
  11. Ye, J. et al. (2010) EMBO J. 29:2082.
  12. Pieters, R. et al. (2011) Cancer 117:238.
  13. Lorenzi, P. L. et al. (2008) Mol. Cancer Ther. 7:3123.
  14. Dufour, E. et al. (2012) Pancreas. 41:940.
  15. Du, F. et al. (2019) Cell Death Dis. 10:239.

Long Name

ASNS

Alternate Names

ASNSD, EC 6.3.5.4, Glutamine Dependent Asparagine Synthetase, TS11 Cell Cycle Control Protein

Entrez Gene IDs

440 (Human); 27053 (Mouse); 25612 (Rat)

Gene Symbol

ASNS

UniProt

P08243-1

Additional Asparagine Synthetase/ASNS Products

Product Documents for Recombinant Human Asparagine Synthetase/ASNS His Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human Asparagine Synthetase/ASNS His Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.